Investigating the Influence of Anaesthesiology for Cancer Resection Surgery on Oncologic Outcomes: The Role of Experimental In Vivo Models.
anaesthesia
animal model
cancer
cancer recurrence
cancer surgery
in vivo model
surgery
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
01 Oct 2022
01 Oct 2022
Historique:
received:
13
07
2022
revised:
29
08
2022
accepted:
26
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
The incidence and societal burden of cancer is increasing globally. Surgery is indicated in the majority of solid tumours, and recent research in the emerging field of onco-anaesthesiology suggests that anaesthetic-analgesic interventions in the perioperative period could potentially influence long-term oncologic outcomes. While prospective, randomised controlled clinical trials are the only research method that can conclusively prove a causal relationship between anaesthetic technique and cancer recurrence, live animal (in vivo) experimental models may more realistically test the biological plausibility of these hypotheses and the mechanisms underpinning them, than limited in vitro modelling. This review outlines the advantages and limitations of available animal models of cancer and how they might be used in perioperative cancer metastasis modelling, including spontaneous or induced tumours, allograft, xenograft, and transgenic tumour models.
Identifiants
pubmed: 36295541
pii: medicina58101380
doi: 10.3390/medicina58101380
pmc: PMC9609581
pii:
doi:
Substances chimiques
Anesthetics
0
Analgesics
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Genes (Basel). 2019 Nov 15;10(11):
pubmed: 31731811
Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:53-66
pubmed: 15209404
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Contemp Clin Trials Commun. 2018 Aug 07;11:156-164
pubmed: 30112460
Nepal J Epidemiol. 2020 Sep 30;10(3):878-887
pubmed: 33042591
Cancer Metastasis Rev. 1990 Sep;9(2):125-36
pubmed: 2253312
Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):221-30
pubmed: 25416501
Brain Behav Immun. 2009 Mar;23(3):318-24
pubmed: 18822367
Br J Pharmacol. 2015 Jan;172(2):251-9
pubmed: 24467261
Bioengineered. 2021 Dec;12(2):9162-9173
pubmed: 34696683
Clin Cancer Res. 2012 Oct 1;18(19):5160-2
pubmed: 22912394
Lancet Oncol. 2020 Aug;21(8):1077-1088
pubmed: 32758462
Br J Anaesth. 2018 Jul;121(1):76-85
pubmed: 29935598
Anticancer Res. 2018 Oct;38(10):5599-5606
pubmed: 30275177
Front Pharmacol. 2011 Aug 08;2:46
pubmed: 21852973
Cancer Biother Radiopharm. 2020 Sep 30;:
pubmed: 32996777
Br J Anaesth. 2014 Jul;113 Suppl 1:i4-13
pubmed: 24861561
Anesthesiology. 2006 Oct;105(4):660-4
pubmed: 17006061
Breast Cancer Res. 2010;12(5):R87
pubmed: 20964822
Front Oncol. 2018 Jul 20;8:268
pubmed: 30079312
Nat Rev Cancer. 2008 Feb;8(2):147-56
pubmed: 18202698
J Recept Signal Transduct Res. 2021 Dec;41(6):538-545
pubmed: 33043765
Eur J Cancer Prev. 2008 Jun;17(3):269-72
pubmed: 18414199
Cancer Med. 2019 Sep;8(12):5574-5576
pubmed: 31397113
Breast Cancer Res Treat. 2006 Mar;96(2):101-13
pubmed: 16319986
Hum Exp Toxicol. 2022 Jan-Dec;41:9603271211065972
pubmed: 35238236
Cancers (Basel). 2019 May 01;11(5):
pubmed: 31052479
Br J Cancer. 2021 Jan;124(1):13-26
pubmed: 33239679
Curr Opin Support Palliat Care. 2016 Jun;10(2):109-18
pubmed: 26990052
Eur J Cancer Prev. 2021 Mar 1;30(2):143-153
pubmed: 32658033
Cancer Manag Res. 2021 Mar 15;13:2455-2475
pubmed: 33758544
Br J Anaesth. 2018 Jan;120(1):188-196
pubmed: 29397129
Cancers (Basel). 2019 Sep 22;11(10):
pubmed: 31546727
Diagnostics (Basel). 2020 Aug 31;10(9):
pubmed: 32878340
Cancer Lett. 2021 Sep 28;516:73-83
pubmed: 34090924
Drug Des Devel Ther. 2014 Oct 14;8:1911-21
pubmed: 25342884